chr16-68833708-C-T
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBS1BS2_Supporting
The ENST00000566612.5(CDH1):n.*1098C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000235 in 509,914 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
ENST00000566612.5 non_coding_transcript_exon
Scores
Clinical Significance
Conservation
Publications
- blepharocheilodontic syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae), G2P
- CDH1-related diffuse gastric and lobular breast cancer syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- hereditary diffuse gastric adenocarcinomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- cleft soft palateInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- orofacial cleft 3Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- blepharocheilodontic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CDH1 | NM_004360.5 | c.*209C>T | 3_prime_UTR_variant | Exon 16 of 16 | ENST00000261769.10 | NP_004351.1 | ||
| CDH1 | NM_001317184.2 | c.*209C>T | 3_prime_UTR_variant | Exon 15 of 15 | NP_001304113.1 | |||
| CDH1 | NM_001317185.2 | c.*209C>T | 3_prime_UTR_variant | Exon 16 of 16 | NP_001304114.1 | |||
| CDH1 | NM_001317186.2 | c.*209C>T | 3_prime_UTR_variant | Exon 15 of 15 | NP_001304115.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000685  AC: 10AN: 146040Hom.:  0  Cov.: 30 show subpopulations 
GnomAD4 exome  AF:  0.000302  AC: 110AN: 363804Hom.:  1  Cov.: 3 AF XY:  0.000271  AC XY: 52AN XY: 192232 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000684  AC: 10AN: 146110Hom.:  0  Cov.: 30 AF XY:  0.0000844  AC XY: 6AN XY: 71096 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Hereditary diffuse gastric adenocarcinoma    Benign:1 
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at